Aclaris Therapeutics, Inc. (Nasdaq:ACRS)
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
701 Lee Road
Suite 103
Wayne, Pennsylvania 19087
91
$1.2700
1.2400 - 1.3000
0.5902 - 11.1200
2.33M
5.83M (02/15/24)
9.04%
$88.66M
$31.25M
N/A
N/A
Independent Director William D Humphries MBA |
Independent Director Maxine Gowen PhD, MBA |
Lead Independent Director Christopher P Molineaux |
Independent Director Andrew Kenneth William Powell |
Independent Director Bryan Marlen Reasons MBA, CPA |
Independent Director Vincent J Milano CPA |
Independent Director Andrew N Schiff MD, MBA |
Independent Director Anand Mehra MD |
Date | Form | Event |
---|---|---|
19 Dec, 2024 | S-3 | |
12 Dec, 2024 | 4 | |
6 Dec, 2024 | 4 | |
4 Dec, 2024 | D | |
3 Dec, 2024 | 4 | |
3 Dec, 2024 | 4 | |
27 Nov, 2024 | S-8 | |
25 Nov, 2024 | 3 | |
25 Nov, 2024 | SC 13G | |
22 Nov, 2024 | SC 13G | |
21 Nov, 2024 | SC 13G | |
20 Nov, 2024 | 4 | |
18 Nov, 2024 | 3 | |
18 Nov, 2024 | 8-K | |
14 Nov, 2024 | SC 13G/A | |
6 Nov, 2024 | 10-Q | |
6 Nov, 2024 | 8-K | |
5 Nov, 2024 | 4 | |
9 Oct, 2024 | SC 13G/A | |
3 Oct, 2024 | 4 | |
4 Sep, 2024 | 4 | |
4 Sep, 2024 | 4 | |
13 Aug, 2024 | 4 | |
7 Aug, 2024 | 8-K | |
7 Aug, 2024 | 10-Q | |
5 Aug, 2024 | 4 | |
5 Aug, 2024 | 4 | |
31 Jul, 2024 | 4 | |
22 Jul, 2024 | 4 | |
16 Jul, 2024 | 8-K | |
8 Jul, 2024 | SC 13G/A | |
5 Jul, 2024 | 4 | |
3 Jul, 2024 | 4 | |
1 Jul, 2024 | 4 | |
18 Jun, 2024 | 4 | |
13 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
7 Jun, 2024 | 8-K | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | 4 | |
4 Jun, 2024 | 4 | |
7 May, 2024 | 10-Q | |
7 May, 2024 | S-8 | |
7 May, 2024 | 8-K | |
3 May, 2024 | 4 | |
25 Apr, 2024 | DEFA14A | |
25 Apr, 2024 | ARS | |
25 Apr, 2024 | DEF 14A | |
3 Apr, 2024 | 4 | |
19 Mar, 2024 | 8-K | |
5 Mar, 2024 | 4 | |
5 Mar, 2024 | 4 | |
5 Mar, 2024 | 4 | |
5 Mar, 2024 | 4 | |
27 Feb, 2024 | 8-K | |
27 Feb, 2024 | 10-K | |
14 Feb, 2024 | SC 13G | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | SC 13G | |
13 Feb, 2024 | SC 13G/A | |
8 Feb, 2024 | 3 | |
8 Feb, 2024 | SC 13G/A | |
5 Feb, 2024 | 8-K | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 8-K/A | |
1 Feb, 2024 | SC 13G/A | |
25 Jan, 2024 | SC 13G/A | |
16 Jan, 2024 | SC 13G | |
3 Jan, 2024 | 4 | |
3 Jan, 2024 | 4 | |
19 Dec, 2023 | 8-K | |
11 Dec, 2023 | SC 13G | |
11 Dec, 2023 | SC 13G/A | |
24 Nov, 2023 | SC 13G | |
13 Nov, 2023 | 8-K | |
6 Nov, 2023 | 10-Q | |
6 Nov, 2023 | 8-K | |
25 Oct, 2023 | 4 | |
23 Oct, 2023 | 144 | |
18 Sep, 2023 | 8-K | |
7 Sep, 2023 | 4 | |
5 Sep, 2023 | SC 13G | |
5 Sep, 2023 | 4 | |
28 Aug, 2023 | 4 | |
22 Aug, 2023 | 4 | |
21 Aug, 2023 | 144 | |
7 Aug, 2023 | 10-Q | |
7 Aug, 2023 | 8-K | |
3 Aug, 2023 | 4 | |
5 Jul, 2023 | 4 | |
22 Jun, 2023 | 4 | |
22 Jun, 2023 | 4 | |
12 Jun, 2023 | 8-K | |
5 Jun, 2023 | 4 | |
5 Jun, 2023 | 4 | |
5 Jun, 2023 | 4 | |
5 Jun, 2023 | 4 | |
5 Jun, 2023 | 4 | |
5 Jun, 2023 | 4 | |
5 Jun, 2023 | 4 | |
5 Jun, 2023 | 4 | |
2 Jun, 2023 | 8-K | |
1 Jun, 2023 | 8-K | |
8 May, 2023 | S-8 | |
8 May, 2023 | 8-K | |
8 May, 2023 | 10-Q | |
20 Apr, 2023 | DEFA14A | |
20 Apr, 2023 | DEF 14A | |
20 Apr, 2023 | ARS | |
14 Apr, 2023 | 8-K | |
10 Apr, 2023 | PRE 14A | |
10 Apr, 2023 | SC 13G/A | |
31 Mar, 2023 | 8-K | |
27 Mar, 2023 | 8-K | |
17 Mar, 2023 | 4 | |
16 Mar, 2023 | SC 13G | |
9 Mar, 2023 | 4 | |
6 Mar, 2023 | 8-K | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
23 Feb, 2023 | 8-K | |
23 Feb, 2023 | 10-K | |
23 Feb, 2023 | 8-K | |
23 Feb, 2023 | 424B5 | |
17 Feb, 2023 | 4 | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
13 Feb, 2023 | SC 13G/A | |
10 Feb, 2023 | 4 | |
6 Feb, 2023 | SC 13G/A | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
31 Jan, 2023 | SC 13G/A | |
20 Jan, 2023 | 4 | |
9 Jan, 2023 | 8-K | |
6 Jan, 2023 | 8-K | CEO Change |
6 Jan, 2023 | 3 | |
4 Jan, 2023 | 4 | |
16 Dec, 2022 | 4 | |
13 Dec, 2022 | 8-K | |
22 Nov, 2022 | 8-K | |
14 Nov, 2022 | 4 | |
8 Nov, 2022 | 8-K | |
8 Nov, 2022 | 10-Q | |
26 Oct, 2022 | 4 | |
19 Oct, 2022 | 4 | |
19 Oct, 2022 | 4 | |
11 Oct, 2022 | 4 | |
6 Oct, 2022 | 4 | |
3 Aug, 2022 | 8-K | |
3 Aug, 2022 | 10-Q | |
2 Aug, 2022 | 3 | |
2 Aug, 2022 | 4 | |
1 Aug, 2022 | 8-K | CEO Change |
5 Jul, 2022 | 3 | |
5 Jul, 2022 | 4 | |
21 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
3 Jun, 2022 | 8-K | |
10 May, 2022 | 8-K | |
10 May, 2022 | S-8 | |
10 May, 2022 | 10-Q | |
25 Apr, 2022 | SC 13G | |
25 Apr, 2022 | 4 | |
21 Apr, 2022 | DEFA14A | |
21 Apr, 2022 | DEF 14A | |
20 Apr, 2022 | 4 | |
14 Apr, 2022 | 8-K | |
14 Mar, 2022 | 4 | |
14 Mar, 2022 | 4 | |
14 Mar, 2022 | 4 | |
3 Mar, 2022 | 4 | |
3 Mar, 2022 | 4 | |
3 Mar, 2022 | 4 | |
24 Feb, 2022 | 8-K | |
24 Feb, 2022 | 10-K | |
15 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G | |
11 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | 4 | |
11 Feb, 2022 | 4 | |
11 Feb, 2022 | 4 | |
10 Feb, 2022 | SC 13G/A | |
10 Feb, 2022 | SC 13G/A | |
4 Feb, 2022 | SC 13G | |
4 Feb, 2022 | SC 13G | |
3 Feb, 2022 | 4 | |
3 Feb, 2022 | 4 | |
3 Feb, 2022 | 4 | |
1 Feb, 2022 | 4 | |
1 Feb, 2022 | 3 | |
24 Jan, 2022 | SC 13G | |
14 Jan, 2022 | 8-K | |
5 Jan, 2022 | 4 | |
7 Dec, 2021 | 8-K | |
3 Dec, 2021 | 4 | |
22 Nov, 2021 | 4 | |
3 Nov, 2021 | 4 | |
2 Nov, 2021 | 8-K | |
2 Nov, 2021 | 10-Q | |
2 Sep, 2021 | 4 | |
27 Aug, 2021 | 8-K | |
5 Aug, 2021 | 10-Q | |
5 Aug, 2021 | 8-K | |
26 Jul, 2021 | 8-K | |
14 Jul, 2021 | 4 | |
7 Jul, 2021 | 4 | |
11 Jun, 2021 | 8-K | |
10 Jun, 2021 | 424B5 | |
8 Jun, 2021 | 424B5 | |
8 Jun, 2021 | 8-K | |
4 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
4 Jun, 2021 | 4 | |
3 Jun, 2021 | 8-K | |
2 Jun, 2021 | 4 | |
2 Jun, 2021 | 4 | |
2 Jun, 2021 | 4 | |
2 Jun, 2021 | 4 | |
2 Jun, 2021 | 4 | |
20 May, 2021 | 8-K | |
20 May, 2021 | S-3ASR | |
17 May, 2021 | 3 | |
7 May, 2021 | 8-K | |
7 May, 2021 | 10-Q | |
7 May, 2021 | 4 | |
7 May, 2021 | S-8 | |
5 May, 2021 | 4 | |
26 Apr, 2021 | 4 | |
26 Apr, 2021 | 4 | |
22 Apr, 2021 | DEFA14A | |
22 Apr, 2021 | DEF 14A | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
3 Mar, 2021 | 4 | |
25 Feb, 2021 | 8-K | |
25 Feb, 2021 | 10-K | |
16 Feb, 2021 | SC 13G/A | |
12 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | SC 13G/A | |
10 Feb, 2021 | 3 | |
3 Feb, 2021 | 4 | |
3 Feb, 2021 | 4 | |
3 Feb, 2021 | 4 | |
3 Feb, 2021 | 4 | |
22 Jan, 2021 | 8-K | |
20 Jan, 2021 | 424B5 | |
20 Jan, 2021 | S-3MEF | |
19 Jan, 2021 | 424B5 | |
19 Jan, 2021 | 8-K |
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.